Cambridge, United Kingdom
AstraZeneca will break ground in early 2015 on its $500 million Global R&D Centre and Corporate Headquarters in Cambridge in the United Kingdom. Providing sophisticated pharmaceutical discovery and development facilities, the project will include space for biologics research, high throughput screening, medicinal chemistry, pre-clinical research, and clinical development. The 11-acre campus will accommodate approximately 2,000 employees. BREAM Excellent sustainable design certification will be sought for the project, which will feature green roofs and the largest ground source heat pump in Europe. Occupancy is expected in late 2016.
Source
